Page 1,263«..1020..1,2621,2631,2641,265..1,2701,280..»

Overhydration Is a Risk Factor for Post-Dialysis Hypertension – Renal and Urology News

Posted: Published on November 11th, 2019

WASHINGTONPatients on hemodialysis (HD)patients who experience an increase in their extracellular water to total bodywater ratio (ECW/TBW) tend to develop post-dialysis hypertension and, in turn, heightentheir risks for early death, investigators reported at the American Society ofNephrologys Kidney Week 2019 meeting. Of 254 prevalent HD patients (mean age 59years; 38% female), 29.1% had an increase in systolic blood pressure (SBP) of10 mm Hg or more after a midweek dialysis session based on bioimpedance analyses,Hyeong cheon Park, MD, of Gangnam Severance Hospital in South Korea, andcolleagues reported. Compared with the nonhypertensive group,the hypertensive group was significantly older (64.3 vs 56.8 years) and morelikely to be using diuretics (45.9% vs 29.4%). Continue reading

Posted in Hypertension | Comments Off on Overhydration Is a Risk Factor for Post-Dialysis Hypertension – Renal and Urology News

Severe Hypertension Common in aHUS Patients and Soliris Effective at Treating Them, Study Finds – aHUS News

Posted: Published on November 11th, 2019

Severe and life-threateninghypertension is common in people with atypical hemolytic uremic syndrome (aHUS), and Soliris(eculizumab) is a more effective than plasmapheresis in treating these patients, a Spanish study finds. The study, Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome, was published in the journal Kidney International. aHUS belongs to a group of rare disorders called thrombotic microangiopathies (TMAs), which are characterized by the presence of hemolytic anemia (destruction of red blood cells), low levels of platelets, and the formation of blood clots in small blood vessels that lead to organ damage Continue reading

Posted in Hypertension | Comments Off on Severe Hypertension Common in aHUS Patients and Soliris Effective at Treating Them, Study Finds – aHUS News

Global Idiopathic Intracranial Hypertension Therapeutics Market 2019-2023 | Evolving Opportunities with AbbVie Inc. and Astellas Pharma Inc. |…

Posted: Published on November 11th, 2019

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the global idiopathic intracranial hypertension therapeutics market and the market is poised to grow by USD 15.34 million during 2019-2023, progressing at a CAGR of almost 3% during the forecast period. Request Free Sample Pages Read the 153-page research report with TOC on "Idiopathic Intracranial Hypertension Therapeutics Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Product (Carbonic anhydrase inhibitors and Other drug classes), and Segment Forecasts, 2019-2023" Continue reading

Posted in Hypertension | Comments Off on Global Idiopathic Intracranial Hypertension Therapeutics Market 2019-2023 | Evolving Opportunities with AbbVie Inc. and Astellas Pharma Inc. |…

This Is What Makes Oats Idli An Ideal Breakfast For A High Blood Pressure Diet – NDTV Food

Posted: Published on November 11th, 2019

Highlights It is not for nothing that oats have become a modern-day superfood. Continue reading

Posted in Hypertension | Comments Off on This Is What Makes Oats Idli An Ideal Breakfast For A High Blood Pressure Diet – NDTV Food

My husband was a veteran. He died from an opioid addiction and shame. – Vox.com

Posted: Published on November 11th, 2019

In November 2008, I found my husband Cleve in bed next to me as usual. What was unusual was that he was turning purple and suffocating on his own vomit Continue reading

Posted in Brain Injury Treatment | Comments Off on My husband was a veteran. He died from an opioid addiction and shame. – Vox.com

Other Than Honorable? Veterans With Bad Paper Seek Long Overdue Benefits – Beyond Chron

Posted: Published on November 11th, 2019

On Veterans Day this year, in a nation now reflexively thankful for military service of all kinds, nearly 500,000 former service members are not included in our official expressions of gratitude. Continue reading

Posted in Brain Injury Treatment | Comments Off on Other Than Honorable? Veterans With Bad Paper Seek Long Overdue Benefits – Beyond Chron

Fighting the Agent Orange Battle of the 9/11 Generation – OZY

Posted: Published on November 11th, 2019

While Le Roy Torres was serving in Iraq, the fires raged. Using jet fuel as an accelerant, military contractor KBR indiscriminately incinerated discarded plastics, medical waste, spent munitions and biological remains. Continue reading

Posted in Brain Injury Treatment | Comments Off on Fighting the Agent Orange Battle of the 9/11 Generation – OZY

Alnylam Initiates ILLUMINATE-C Phase 3 Study of Lumasiran for the Treatment of Advanced Primary Hyperoxaluria Type 1 and Presents New Positive Results…

Posted: Published on November 11th, 2019

DetailsCategory: DNA RNA and CellsPublished on Sunday, 10 November 2019 14:10Hits: 294 Initial Results From ILLUMINATE-C Expected in Late 2020 In Phase 2 OLE, Lumasiran Treatment Resulted in 76 percent Mean Maximal Reduction in Urinary Oxalate Relative to Phase 1/2 Baseline CAMBRIDGE, MA, USA I November 09, 2019 IAlnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company has initiated ILLUMINATE-C, a new global Phase 3 study of lumasiran, an investigational, subcutaneously administered RNAi therapeutic in development for the treatment of primary hyperoxaluria type 1 (PH1). The study will enroll patients of all ages with advanced renal disease, and the primary study endpoint is the percent reduction in plasma oxalate from baseline to six months. Continue reading

Posted in Brain Injury Treatment | Comments Off on Alnylam Initiates ILLUMINATE-C Phase 3 Study of Lumasiran for the Treatment of Advanced Primary Hyperoxaluria Type 1 and Presents New Positive Results…

Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange – Xconomy

Posted: Published on November 11th, 2019

XconomySan Francisco These are heady times for neuroscience research. Startups developing new approaches to brain disorders are raising money to advance their discoveries toward clinical trials Continue reading

Posted in Brain Injury Treatment | Comments Off on Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange – Xconomy

Jurgen Klopp welcomes Sen Cox and his family to Anfield: "It was a wonderful day for them" – Off The Ball

Posted: Published on November 11th, 2019

Sen Cox and his family returned to Anfield for the first time yesterday since he suffered a serious brain injury following an assault outside the stadium. Sen was accompanied by his wife Martina and his son in the stands to watch Liverpool defeat Manchester City 3-1 in the Premier League. Sen Cox has been receiving rehabilitative treatment in Sheffield in the wake of the unprovoked attack by a Roma supporter in 2018 which changed his life Continue reading

Posted in Brain Injury Treatment | Comments Off on Jurgen Klopp welcomes Sen Cox and his family to Anfield: "It was a wonderful day for them" – Off The Ball

Page 1,263«..1020..1,2621,2631,2641,265..1,2701,280..»